DECN — Decision Diagnostics Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $3.14m
- $1.98m
Annual income statement for Decision Diagnostics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2016 December 31st | 2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PRESS | ARS | ARS | ARS | ARS |
Standards: | — | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.09 | 1.88 | 2.24 | 2.38 | 1.98 |
Cost of Revenue | |||||
Gross Profit | 0.49 | 0.314 | 0.781 | 0.85 | 0.498 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3.95 | 4.52 | 4.09 | 2.5 | 4.39 |
Operating Profit | -2.86 | -2.64 | -1.85 | -0.117 | -2.42 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.18 | -2.99 | -2.24 | -3.13 | -29.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.18 | -2.99 | -2.24 | -3.13 | -29.7 |
Net Income Before Extraordinary Items | |||||
Net Income | -3.18 | -2.99 | -2.24 | -3.13 | -29.7 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.18 | -2.99 | -2.24 | -3.13 | -29.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.054 | -0.03 | -0.018 | -0.029 | -0.11 |